LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy

Summary

This is a double-blind, placebo-controlled, study testing whether LDX improves cognitive function and EF in 20 postmenopausal women who report onset of cognitive difficulties after oophorectomy (with or without subsequent chemo/adjunctive therapy). Brain imaging is included at critical time points to obtain objective data regarding effects of LDX as well as potential predictors of resilience in the face of oophorectomy.

Timeline

Start

2013-07

Primary completion

2013-12

Completion

2013-12

Drugs

Indications